Virtus Investment Advisers, Inc. Prothena Corp Public LTD CO Transaction History
Virtus Investment Advisers, Inc.
- $286 Million
- Q2 2025
A detailed history of Virtus Investment Advisers, Inc. transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Virtus Investment Advisers, Inc. holds 18,547 shares of PRTA stock, worth $192,332. This represents 0.04% of its overall portfolio holdings.
Number of Shares
18,547
Previous 11,891
55.98%
Holding current value
$192,332
Previous $147,000
23.81%
% of portfolio
0.04%
Previous 0.05%
Shares
2 transactions
Others Institutions Holding PRTA
# of Institutions
217Shares Held
34.1MCall Options Held
879KPut Options Held
791K-
Black Rock Inc. New York, NY3.86MShares$40 Million0.0% of portfolio
-
Adar1 Capital Management, LLC Austin, TX3.38MShares$35 Million3.14% of portfolio
-
Armistice Capital, LLC New York, NY2.24MShares$23.2 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.18MShares$22.6 Million0.0% of portfolio
-
Palo Alto Investors LP Palo Alto, CA1.27MShares$13.2 Million1.75% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $487M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...